These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6106550)

  • 1. Evaluation of a radioreceptor assay for beta-adrenoceptor antagonists in plasma.
    Barnett DB; Batta M; Davies B; Nahorski SR
    Eur J Clin Pharmacol; 1980 May; 17(5):349-54. PubMed ID: 6106550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.
    Wellstein A; Palm D; Wiemer G; Schäfer-Korting M; Mutschler E
    Eur J Clin Pharmacol; 1984; 27(5):545-53. PubMed ID: 6151508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and activity of beta-adrenoceptor antagonists in the rat using an ex vivo receptor binding assay.
    Sriwatanakul K; Nahorski SR
    Eur J Pharmacol; 1980 Aug; 66(2-3):169-78. PubMed ID: 6108223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of beta-adrenoceptor antagonists in biological fluids using a radioreceptor assay.
    Nahorski SR; Batta MI; Barnett DB
    Eur J Pharmacol; 1978 Dec; 52(3-4):393-6. PubMed ID: 32055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
    Rankin A; Broadley KJ
    Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioreceptor assay in which iodocyanopindolol is used to determine propranolol and its active metabolites in unextracted serum or plasma.
    Elkins RP; Kelly JF; Rosenberg BJ
    Clin Chem; 1986 Jan; 32(1 Pt 1):180-3. PubMed ID: 2866853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding properties of beta-adrenergic receptors in early human fetal lung.
    Falkay G; Németh G; Kovács L
    Biochem Biophys Res Commun; 1986 Mar; 135(3):816-22. PubMed ID: 2870714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to analysis of radiolabeled ligand interactions with specific receptors.
    Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
    Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique.
    Hancock AA; DeLean AL; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):1-9. PubMed ID: 39239
    [No Abstract]   [Full Text] [Related]  

  • 12. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A; Palm D; Pitschner HF; Belz GG
    Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of radiolabelled ligands with specific receptors: an analysis.
    Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
    Membr Cell Biol; 2000; 13(5):667-85. PubMed ID: 10987390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.
    Yamanouye N; Carneiro SM; Scrivano CN; Markus RP
    Life Sci; 2000 Jun; 67(3):217-26. PubMed ID: 10983865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of beta adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses.
    Barnes PJ; Nadel JA; Skoogh BE; Roberts JM
    J Pharmacol Exp Ther; 1983 May; 225(2):456-61. PubMed ID: 6132993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
    Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
    Sillence MN; Moore NG; Pegg GG; Lindsay DB
    Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.